AbbVie Inc. (4AB)
XETR
Real-time Data
07:00 AM
Day's Range
222.6052 wk Range
162.85Overview - 4AB - AbbVie Inc.
Key Statistics
Valuation
Enterprise Value
399.37B
P/E (Trailing)
‪75.28‬
PEG Ratio
‪0.26‬
Price / Sales (TTM)
‪6.26‬
Price / Book
‪-68.68‬
EV / EBITDA
‪15.19‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪9.80%‬
Operating Margin
‪40.03%‬
Return on Assets
‪10.51%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Held by Insiders
‪0.11%‬
Held by Institutions
‪77.43%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪215.94‬
200-Day Avg
‪194.96‬
Dividends
Payout Ratio
‪190.39%‬
Frequency
Quarterly
Market Cap - 4AB - AbbVie Inc.
Peers - 4AB - AbbVie Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
- 4ABXETRAbbVie Inc.403.07BMarket Cap+21.79%52-week change74.52P/E (Trailing)‪9.80%‬Profit Margin
- LLYXETREli Lilly and Company967.83BMarket Cap+44.68%52-week change42.40P/E (Trailing)‪33.52%‬Profit Margin
- JNJXETRJohnson & Johnson560.78BMarket Cap+34.27%52-week change31.45P/E (Trailing)‪21.48%‬Profit Margin
- 6MKXETRMerck & Co., Inc.324.08BMarket Cap+44.20%52-week change123.92P/E (Trailing)‪4.76%‬Profit Margin
- RHOXETRRoche Holding AG323.64BMarket Cap+28.61%52-week change24.90P/E (Trailing)‪19.60%‬Profit Margin
- NOTXETRNovartis AG259.02BMarket Cap+20.99%52-week change23.66P/E (Trailing)‪22.50%‬Profit Margin
- ZEGXETRAstraZeneca PLC249.22BMarket Cap+14.75%52-week change28.34P/E (Trailing)‪17.02%‬Profit Margin
Profile Summary - 4AB - AbbVie Inc.
About
AbbVie Inc. is a research-based biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative medicines and therapies worldwide. Headquartered in North Chicago, Illinois, and founded in 2012 as a spin-off from Abbott Laboratories, it employs approximately 55,000…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
